Journal article · 2008 · Open access

Biochemical Aspects, Laboratory Diagnosis and Follow-Up of High Blood Cholesterol: NCEP ATP III Guidelines

Snežana Ž. Jovičić

Journal of Medical Biochemistry, 27(1), 64–85 · Published 1 January 2008 · DOI 10.2478/v10011-007-0044-2

Free PDFView at the publisherCite this paper

In brief

“Biochemical Aspects, Laboratory Diagnosis and Follow-Up of High Blood Cholesterol: NCEP ATP III Guidelines” is a 2008 journal article by Snežana Ž. Jovičić, published in Journal of Medical Biochemistry. OpenAlex counts 0 citations as of 15 November 2026. It is open access under a CC BY licence: the full text is free to read at Journal of Medical Biochemistry.

Citations
0
References
91
Authors
1

Abstract

Biohemijski Aspekti, Laboratorijska Dijagnoza I Praćenje Povišene Koncentracije Holesterola: PreporukeNCEP ATP III Treći izveštaj ekspertske grupe o detekciji, evaluaciji i tretmanu povišene koncentracije holesterola u odraslih (Adult Treatment Panel III, ATP III) predstavlja ažuriran klinički vodič Nacionalnog programa edukacije o holesterolu (National Cholesterol Education Program, NCEP), o određivanju holesterola i zbrinjavanju osoba s povišenom koncentracijom holesterola u serumu. Pored toga što preporučuje intenzivan tretman pacijenata sa koronarnom srčanom bolešću (coronary heart disease/CHD), važna karakteristika ATP III je težište na primarnoj prevenciji kod osoba sa više prisutnih faktora rizika. ATP III nastavlja da identifikuje povišene koncentracije LDL holesterola kao primarni cilj terapije za snižavanje holesterola. Osnovni princip prevencije je da se intenzitet terapije prilagođava apsolutnom riziku za CHD svake osobe pojedinačno. Procena rizika podrazumeva određivanje LDL holesterola u sklopu analize lipoproteina i identifikaciju pratećih determinanti rizika (prisustvo ili odsustvo CHD, drugih kliničkih oblika aterosklerotske bolesti i dijabetesa, pušenje, hipertenzija, niska koncentracija HDL holesterola, porodična anamneza prevremene pojave CHD, starost). U kategoriji najvišeg rizika nalaze se osobe sa CHD i CHD ekvivalentima rizika, čiji je apsolutni rizik od pojave srčane smrti ili nefatalnog infarkta miokarda u narednih 10 godina ≥20%. Drugu kategoriju čine osobe sa dva ili više faktora rizika kod kojih je 10-godišnji rizik <20%. Apsolutni rizik se procenjuje na osnovuFraminghamrizik skora. U trećoj kategoriji su osobe sa jednim ili nijednim faktorom rizika. Definisane su preporučene koncentracije LDL holesterola za svaku kategoriju i postižu se korekcijom ishrane i/ili farmakoterapijom. Evropske preporuke za prevenciju kardiovaskularne bolesti (cardiovascular disease, CVD) u kliničkoj praksi preporučuju upotrebu SCO-RE (Systematic COronary Risk Evaluation) tablica za procenu rizika za pojavu CVD, koje podrazumevaju apsolutnu verovatnoću za fatalan ishod CVD u toku 10 godina. Cilj ovog rada je predstavljanje delova NCEP ATP III i evropskih preporuka značajnih za njihovu implementaciju u laboratorijsku praksu.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Jovičić, S. Ž. (2008). Biochemical Aspects, Laboratory Diagnosis and Follow-Up of High Blood Cholesterol: NCEP ATP III Guidelines. Journal of Medical Biochemistry, 27(1), 64–85. https://doi.org/10.2478/v10011-007-0044-2

MLA 9

Jovičić, Snežana Ž. “Biochemical Aspects, Laboratory Diagnosis and Follow-Up of High Blood Cholesterol: NCEP ATP III Guidelines.” Journal of Medical Biochemistry, vol. 27, no. 1, 2008, pp. 64–85. https://doi.org/10.2478/v10011-007-0044-2.

Chicago

Jovičić, Snežana Ž. 2008. “Biochemical Aspects, Laboratory Diagnosis and Follow-Up of High Blood Cholesterol: NCEP ATP III Guidelines.” Journal of Medical Biochemistry 27 (1): 64–85. https://doi.org/10.2478/v10011-007-0044-2.

Harvard

Jovičić, S. Ž. (2008) ‘Biochemical Aspects, Laboratory Diagnosis and Follow-Up of High Blood Cholesterol: NCEP ATP III Guidelines’, Journal of Medical Biochemistry, 27(1), pp. 64–85. doi:10.2478/v10011-007-0044-2.

IEEE

S. Ž. Jovičić, “Biochemical Aspects, Laboratory Diagnosis and Follow-Up of High Blood Cholesterol: NCEP ATP III Guidelines,” Journal of Medical Biochemistry, vol. 27, no. 1, pp. 64–85, 2008, doi: 10.2478/v10011-007-0044-2.

BibTeX

@article{jovicic2008biochemical,
  title     = {{Biochemical Aspects, Laboratory Diagnosis and Follow-Up of High Blood Cholesterol: NCEP ATP III Guidelines}},
  author    = {Jovičić, Snežana Ž.},
  journal   = {Journal of Medical Biochemistry},
  year      = {2008},
  volume    = {27},
  number    = {1},
  pages     = {64--85},
  doi       = {10.2478/v10011-007-0044-2},
  url       = {https://doi.org/10.2478/v10011-007-0044-2}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health

  • hypercholesterolemia
  • NCEP ATP III guidelines
  • LDL cholesterol
  • coronary artery disease
  • primary prevention
  • cardiovascular risk assessment
  • absolute risk estimation
  • lipid-lowering therapy

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Jovičić, S. Ž. (2008). Biochemical Aspects, Laboratory Diagnosis and Follow-Up of High Blood Cholesterol: NCEP ATP III Guidelines. Journal of Medical Biochemistry, 27(1), 64–85. https://doi.org/10.2478/v10011-007-0044-2

How many times has this paper been cited?

0 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at Journal of Medical Biochemistry.

Who wrote this paper?

Snežana Ž. Jovičić.

What is the DOI of this paper?

10.2478/v10011-007-0044-2. The permanent link is https://doi.org/10.2478/v10011-007-0044-2.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.